<DOC>
	<DOCNO>NCT00003737</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness rebeccamycin analog treat child relapse refractory neuroblastoma .</brief_summary>
	<brief_title>Rebeccamycin Analog Treating Children With Relapsed Refractory Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate rebeccamycin analogue child relapse refractory neuroblastoma . - Determine toxicity drug patient . - Identify establish vitro biologic correlate clinical response toxicity drug patient . OUTLINE : Patients receive rebeccamycin analogue IV 1 hour day 1-5 . Treatment repeat every 3 week least 2 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : This study accrue 30 patient within 1.5 year .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven relapsed refractory neuroblastoma Measurable disease PATIENT CHARACTERISTICS : Age : Children Performance status : ECOG 02 Life expectancy : At least 2 month Hematopoietic : Not specify Hepatic : Bilirubin le 1.5 mg/dL SGOT SGPT less 2.5 time upper limit normal ( ULN ) Adequate liver function unless due disease Renal : Creatinine great 1.5 time ULN OR Creatinine clearance least 60 mL/min Adequate renal function unless due disease Other : No serious concurrent illness No active uncontrolled infection Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Recovered prior immunotherapy Prior autologous bone marrow transplantation allow No concurrent immunotherapy Chemotherapy : At least 4 week since prior chemotherapy recover No concurrent systemic chemotherapy Endocrine therapy : Not specify Radiotherapy : Recovered prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>recurrent neuroblastoma</keyword>
</DOC>